Delivery of a Therapeutic Protein, Transthyretin (TTR), Across the Blood-Brain Barrier (BBB) as a Treatment for Alzheimer's Disease
Lead Inventor: Juan Marugan (NCATS)
Inventors: Silvia Muro-Galindo (University of Maryland Biotechnology Institute), Wei Zheng (NCATS)
Ref. No.: E-268-2009/0
Abstract: This invention describes products and methods of treating Alzheimer's disease, which is characterized by the formation of amyloid plaques and tangles in areas of the brain critical for learning and memory.